UBS has reaffirmed its "Buy" rating on Option Care Health stock, maintaining a target price of $39 per share. This decision reflects the firm's confidence in the company's performance and growth potential within the healthcare sector. Investors may view this as a positive indicator of Option Care Health's market position and future profitability.
Related Articles
Don't miss out on breaking stories and in-depth articles.